Research On The Profit Model Of N Gene Sequencing Company

The outbreak of novel coronavirus in 2019 triggered a global war against the epidemic.Gene sequencing technology played a crucial role during this period.It can help people determine the type,source,and mutation of the virus through gene sequencing of virus samples,providing strong support for the development of targeted prevention and control measures.Currently,with the increasing emphasis on health,the market demand for gene sequencing is also growing.This new detection method can predict potential diseases in advance by extracting gene fragments from samples,measuring gene sequences,and conducting comparative analysis,providing more accurate services for people’s health protection.With the expansion of market demand for gene sequencing technology,the application fields are also constantly expanding,attracting more capital to flow into the gene sequencing industry,leading to sustained growth in the entire industry scale and increasingly fierce competition.In this context,enterprises must have a clear understanding of their profit model,identify problems,and take effective measures to improve,in order to maintain core competitiveness and achieve long-term development.This article takes gene sequencing company N as the research object,and through in-depth analysis from both vertical and horizontal dimensions,it is found that its profit model has the following problems: low turnover rate of accounts receivable,making it difficult to effectively manage the accounts of profit objects;The profit source and profit point are relatively single,with low gross profit margin and net profit margin levels;Poor profit leverage,reliance on a single supplier,high cost sequencing instruments and reagents,high sales expenses,and pressure on corporate profitability;Lack of strong core competitiveness forms a profit barrier,and employee layoffs have caused damage to the company’s image.In response to the above issues,this article analyzes the reasons and proposes the following suggestions: to strengthen the management of profit object collection,especially to standardize the management of overseas accounts receivable,in order to improve turnover rate;Entering the field of clinical medicine,expanding profit sources and profit points;Reduce costs and expenses by increasing the number of suppliers and adopting internet sales methods,and increase profit leverage;Increase research investment and establish core competitiveness;Improve employee management system,strengthen talent resources,and build a strong profit barrier.